Prosecution Insights
Last updated: April 19, 2026

Forty Seven LLC

2 pending office actions

Portfolio Summary

2
Total Pending OAs
2
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17916994 ANTIBODY FORMULATION HADDAD, MAHER M 1641 Final Rejection Oct 04, 2022
17291397 GENETICALLY MODIFIED HSPCS RESISTANT TO ABLATION REGIME BATES, KEENAN ALEXANDER 1631 Final Rejection May 05, 2021

Managing Forty Seven LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month